March 24, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE (“Valneva” or “the Company”) (NASDAQ: VALN). Investors who purchased Valneva securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Valneva has violated federal… read more
March 24, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE (“Valneva” or “the Company”) (NASDAQ: VALN). Investors who purchased Valneva securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Valneva has violated federal… read more
March 24, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE (“Valneva” or “the Company”) (NASDAQ: VALN). Investors who purchased Valneva securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Valneva has violated federal… read more
March 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Microvast Holdings, Inc. (“Microvast” or “the Company”) (NASDAQ: MVST). Investors who purchased Microvast securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Microvast has violated… read more
March 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FS KKR Capital Corp. (“FSK” or “the Company”) (NYSE: FSK). Investors who purchased FSK securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether FSK has… read more
March 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nuvation Bio Inc. (“Nuvation” or “the Company”) (NYSE: NUVB). Investors who purchased Nuvation securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nuvation has violated… read more
March 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Xponential Fitness, Inc. (“Xponential” or “the Company”) (NYSE: XPOF). Investors who purchased Xponential securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Xponential has violated… read more
March 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aardvark Therapeutics, Inc. (“Aardvark” or “the Company”) (NASDAQ: AARD). Investors who purchased Aardvark securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Aardvark has violated… read more
March 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between KORE Group Holdings, Inc. (“KORE”) (NYSE: KORE) and Searchlight Capital Partners and Abry Partners (“Searchlight and Abry”). Investors who purchased KORE and continue to hold to the present are encouraged to obtain additional information and… read more
March 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sunrun Inc. (“Sunrun” or “the Company”) (NASDAQ: RUN). Investors who purchased Sunrun securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sunrun has violated federal… read more
March 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Disc Medicine, Inc. (“Disc Medicine” or “the Company”) (NASDAQ: IRON). Investors who purchased Disc Medicine securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Disc… read more
March 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Freshpet, Inc. (“Freshpet” or “the Company”) (NASDAQ: FRPT). Investors who purchased Freshpet securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Freshpet has violated federal… read more
March 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TruBridge, Inc. (“TruBridge” or “the Company”) (NASDAQ: TBRG). Investors who purchased TruBridge securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether TruBridge has violated federal… read more
March 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of OneMain Holdings, Inc. (“OneMain” or “the Company”) (NYSE: OMF). Investors who purchased OneMain securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether OneMain has violated… read more
March 18, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medical Properties Trust, Inc. (“Medical Properties” or “the Company”) (NYSE: MPT). Investors who purchased Medical Properties securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
March 18, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of IperionX Limited (“IperionX” or “the Company”) (NASDAQ: IPX). Investors who purchased IperionX securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether IperionX has violated federal… read more
March 17, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arq, Inc. (“Arq” or “the Company”) (NASDAQ: ARQ). Investors who purchased Arq securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Arq has violated federal… read more
March 17, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Victoria’s Secret & Co. (“Victoria’s Secret” or “the Company”) (NYSE: VSCO). Investors who purchased Victoria’s Secret securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
March 17, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Insulet Corporation (“Insulet” or “the Company”) (NASDAQ: PODD). Investors who purchased Insulet securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Insulet has violated federal… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vistagen Therapeutics, Inc. (“Vistagen” or “the Company”) (NASDAQ: VTGN). Investors who purchased Vistagen securities prior to April 1, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the sale of National Storage Affiliates Trust (“National Storage”) (NYSE: NSA) to Public Storage for 0.14 of a share of Public Storage common stock or partnership units for each National Storage share or unit. Investors who purchased National… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Horizon Technology Finance Corporation (“Horizon” or “the Company”) (NASDAQ: HRZN). Investors who purchased Horizon securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Horizon has… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Planet Fitness, Inc. (“Planet Fitness” or “the Company”) (NYSE: PLNT). Investors who purchased Planet Fitness securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Planet… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Marriott Vacations Worldwide Corporation (“Marriott Vacations” or “the Company”) (NYSE: VAC). Investors who purchased Marriott Vacations securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Immutep Limited (“Immutep” or “the Company”) (NASDAQ: IMMP). Investors who purchased Immutep securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Immutep has violated federal… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Immutep Limited (“Immutep” or “the Company”) (NASDAQ: IMMP). Investors who purchased Immutep securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Immutep has violated federal… read more
March 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zillow Group, Inc. (“SZillow” or “the Company”) (NASDAQ: ZG). Investors who purchased SZillow securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether SZillow has violated… read more
March 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jefferies Financial Group, Inc. (“Jefferies” or “the Company”) (NYSE: JEF). Investors who purchased Jefferies securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Jefferies has… read more
March 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Via Transportation, Inc. (“Via” or “the Company”) (NYSE: VIA). Investors who purchased Via securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Via has violated… read more
March 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BlackRock, Inc. (“BlackRock” or “the Company”) (NYSE: BLK). Investors who purchased BlackRock securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether BlackRock has violated federal… read more